TAO Kinase 3 Overexpression Is a Poor Prognosis Marker for Lung Adenocarcinoma and Predicts Paclitaxel Resistance
P. M.-H. Chang, T.-C. Lai, Y.-C. Yang, Y.-C. Chang, J. Chiou, M.-S. Huang, C.-J. Yang, M. Hsiao
This study shows TAOK3 overexpression correlates with poor prognosis and paclitaxel resistance in lung adenocarcinoma, suggesting it as a therapeutic target.
bioRxiv · Apr 29, 2019 · PreprintCancer Biology